CRP and cancer: Even after adjustment for age, sex, diabetes mellitus, prior peripheral- and coronary artery disease, MI and prior cancer, as well as LVEF, eGFR < 60 ml/min and c-reactive protein, pharmacological cardioversion remained an independent predictor for all-cause mortality showing an aHR of 2.51 (95%CI: 1.38–4.58), p = 0.0026 (Table 6).